Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Begoña Medina Magan"'
Autor:
Manuel Valladares-Ayerbes, Pilar Garcia-Alfonso, Jorge Muñoz Luengo, Paola Patricia Pimentel Caceres, Oscar Alfredo Castillo Trujillo, Rosario Vidal-Tocino, Marta Llanos, Beatriz Llorente Ayala, Maria Luisa Limon Miron, Antonieta Salud, Luis Cirera Nogueras, Rocio Garcia-Carbonero, Maria Jose Safont, Esther Falco Ferrer, Jorge Aparicio, Maria Angeles Vicente Conesa, Carmen Guillén-Ponce, Paula Garcia-Teijido, Maria Begoña Medina Magan, Isabel Busquier, Mercedes Salgado, Ariadna Lloansí Vila
Publikováno v:
Cancers; Volume 14; Issue 24; Pages: 6075
The serial analysis of cell-free DNA (cfDNA) enables minimally invasive monitoring of tumor evolution, providing continuous genetic information. PERSEIDA was an observational, prospective study assessing the cfDNA RAS (KRAS/NRAS) mutational status ev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6b6d69e18a11de54b71b56e47b6b225
Autor:
Manuel, Valladares-Ayerbes, Pilar, Garcia-Alfonso, Jorge, Muñoz Luengo, Paola Patricia, Pimentel Caceres, Oscar Alfredo, Castillo Trujillo, Rosario, Vidal-Tocino, Marta, Llanos, Beatriz, Llorente Ayala, Maria Luisa, Limon Miron, Antonieta, Salud, Luis, Cirera Nogueras, Rocio, Garcia-Carbonero, Maria Jose, Safont, Esther, Falco Ferrer, Jorge, Aparicio, Maria Angeles, Vicente Conesa, Carmen, Guillén-Ponce, Paula, Garcia-Teijido, Maria Begoña, Medina Magan, Isabel, Busquier, Mercedes, Salgado, Ariadna, Lloansí Vila
Publikováno v:
Cancers. 14(24)
The serial analysis of cell-free DNA (cfDNA) enables minimally invasive monitoring of tumor evolution, providing continuous genetic information. PERSEIDA was an observational, prospective study assessing the cfDNA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d74bf849bbe7622665596f882d02968a
https://pubmed.ncbi.nlm.nih.gov/36551560
https://pubmed.ncbi.nlm.nih.gov/36551560
Autor:
Begoña Medina Magan, Encarna Fernandez Flores, Margarita Fernandez Morales, Pedro Sánchez Rovira, Miguel Angel Moreno Moreno, Ana María Lozano Barriuso, Rosario Dueñas García, Ana Jaén Morago, Ignacio Porras Quintela, N. Mohedano
Publikováno v:
American journal of clinical oncology. 26(4)
A phase II study was conducted to evaluate the safety and efficacy of the combination GIP (gemcitabine, ifosfamide, and cisplatin) for the treatment of patients with advanced non-small-cell lung cancer (NSCLC). Thirty patients with stage III B/IV NSC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e97c2c61c3ce30f90f50cbbb0fc9eaa2
https://pubmed.ncbi.nlm.nih.gov/12902886
https://pubmed.ncbi.nlm.nih.gov/12902886
Autor:
Nicolás Mohedano Mohedano, Pedro Sánchez Rovira, Ana Lozano Barriuso, Margarita Fernandez Morales, Begoña Medina Magan, Ana Jaen Morago, Ignacio Porras Quintela, Rosario Dueñas Garcia, Encarna Fernandez Flores, Miguel Angel Moreno Moreno
Publikováno v:
American Journal of Clinical Oncology; Aug2003, Vol. 26 Issue 4, p363-365, 3p